Production (Stage)
Creative Medical Technology Holdings, Inc.
CELZ
$2.18
-$0.02-0.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.64M | -1.85M | -1.04M | -1.56M | -1.04M |
| Total Depreciation and Amortization | 30.60K | 22.60K | 29.30K | 29.30K | 29.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.50K | 9.20K | 9.20K | 9.20K | 9.20K |
| Change in Net Operating Assets | 12.50K | -127.30K | 16.10K | 50.00K | 106.20K |
| Cash from Operations | -1.59M | -1.95M | -985.60K | -1.47M | -896.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | -200.00K | 0.00 | 6.52M |
| Cash from Investing | -- | 0.00 | -200.00K | 0.00 | 6.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.36M | 1.63M | -- | -- | -- |
| Repurchase of Common Stock | -10.00K | 0.00 | -25.50K | -66.70K | -82.80K |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 100.00 | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.35M | 1.63M | -25.50K | -66.60K | -82.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.76M | -320.00K | -1.21M | -1.54M | 5.54M |